BRPI0919250A2 - métodos para a purificação de vírus - Google Patents

métodos para a purificação de vírus

Info

Publication number
BRPI0919250A2
BRPI0919250A2 BRPI0919250A BRPI0919250A BRPI0919250A2 BR PI0919250 A2 BRPI0919250 A2 BR PI0919250A2 BR PI0919250 A BRPI0919250 A BR PI0919250A BR PI0919250 A BRPI0919250 A BR PI0919250A BR PI0919250 A2 BRPI0919250 A2 BR PI0919250A2
Authority
BR
Brazil
Prior art keywords
methods
virus purification
virus
purification
Prior art date
Application number
BRPI0919250A
Other languages
English (en)
Inventor
Akansha Nagpal
Janice Wee
Mark Thompson
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of BRPI0919250A2 publication Critical patent/BRPI0919250A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18551—Methods of production or purification of viral material
BRPI0919250A 2008-09-24 2009-09-24 métodos para a purificação de vírus BRPI0919250A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9974908P 2008-09-24 2008-09-24
US10493308P 2008-10-13 2008-10-13
US12245608P 2008-12-15 2008-12-15
US18772109P 2009-06-17 2009-06-17
US22213109P 2009-07-01 2009-07-01
PCT/US2009/058174 WO2010036774A1 (en) 2008-09-24 2009-09-24 Methods for purification of viruses

Publications (1)

Publication Number Publication Date
BRPI0919250A2 true BRPI0919250A2 (pt) 2015-12-15

Family

ID=42060079

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919250A BRPI0919250A2 (pt) 2008-09-24 2009-09-24 métodos para a purificação de vírus

Country Status (9)

Country Link
US (1) US8785173B2 (pt)
EP (1) EP2334328A4 (pt)
JP (1) JP5548207B2 (pt)
KR (1) KR20110074563A (pt)
CN (1) CN102215865B (pt)
AU (1) AU2009296628B2 (pt)
BR (1) BRPI0919250A2 (pt)
CA (1) CA2738024A1 (pt)
WO (1) WO2010036774A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2592120A1 (en) 2004-12-23 2006-07-06 Medimmune Vaccines, Inc. Non-tumorigenic mdck cell line for propagating viruses
JP5260525B2 (ja) 2006-09-15 2013-08-14 メディミューン，エルエルシー 高力価までウイルス増殖を支持するｍｄｃｋ細胞株と、それを用いたバイオリアクタープロセス
US8202726B2 (en) 2008-09-24 2012-06-19 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
JP5548207B2 (ja) 2008-09-24 2014-07-16 メディミューン，エルエルシー ウイルスの精製方法
KR20130109004A (ko) * 2010-06-01 2013-10-07 노파르티스 아게 동결건조하지 않는 인플루엔자 백신 항원의 농축
KR20130031351A (ko) 2010-07-30 2013-03-28 이엠디 밀리포어 코포레이션 크로마토그래피 매질 및 방법
EP2625264B1 (en) 2010-10-08 2022-12-07 Terumo BCT, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
ES2812923T3 (es) * 2010-12-27 2021-03-18 Kyowa Kirin Co Ltd Método para preparar una disolución acuosa que contiene medio de cultivo y agente quelante
CN102199198A (zh) * 2011-03-28 2011-09-28 北京交通大学 人呼吸道合胞病毒f蛋白的纯化方法
BR112014001049A2 (pt) * 2011-07-20 2017-02-21 Abbott Biologicals Bv método para a produção de um antígeno viral derivado de vírus envelopado, e, uso de um método para a fabricação de uma preparação de vacina contendo o antígeno viral
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
AU2015259228B2 (en) * 2014-05-13 2020-04-23 Amgen Inc. Process control systems and methods for use with filters and filtration processes
KR102072529B1 (ko) 2014-09-02 2020-02-25 이엠디 밀리포어 코포레이션 나노-피브릴화된 표면 특징을 갖는 고표면적 섬유 매질
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
WO2016093926A1 (en) 2014-12-08 2016-06-16 Emd Millipore Corporation Mixed bed ion exchange adsorber
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US20180273909A1 (en) * 2015-09-22 2018-09-27 Sanofi Pasteur Biologics, Llc Purification of respiratory syncytial virus
CN106337045A (zh) * 2016-05-24 2017-01-18 微基生物科技（上海）有限公司 一种防止pcr污染的方法及其应用
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. CELL EXPANSION
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
WO2018183426A1 (en) * 2017-03-30 2018-10-04 Merck Sharp & Dohme Corp. Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
PE20210106A1 (es) * 2017-10-16 2021-01-19 Serum Institute Of India Pvt Ltd Composiciones de vacuna estables que comprenden inter alia un flavivirus recombinante vivo atenuado y proceso para la preparacion de las mismas
US11339377B2 (en) * 2017-11-08 2022-05-24 Bluesky Immunotherapies Gmbh SO3 chromatography for use in a method for virus purification
PE20210654A1 (es) 2017-12-07 2021-03-31 Merck Sharp & Dohme Formulaciones de composiciones de vacuna contra el virus del dengue
US10988726B2 (en) 2018-08-19 2021-04-27 Cytera Cellworks Limited Systems and methods for automated cell culturing
CN111763661B (zh) * 2019-04-02 2022-07-29 普莱柯生物工程股份有限公司 一种病毒纯化的方法、制备的疫苗组合物及其应用
KR20220153587A (ko) * 2020-03-12 2022-11-18 버베리안 노딕 에이/에스 폭스바이러스 안정성을 개선하는 조성물
JP2023528776A (ja) * 2020-06-11 2023-07-06 ２セブンティ バイオ インコーポレイテッド ウイルスベクターの製造方法
KR20230038205A (ko) * 2020-06-17 2023-03-17 메이사 백신즈, 인크. 키메라 rsv 및 코로나바이러스 단백질, 면역원성 조성물, 및 사용 방법
CN113930353B (zh) * 2021-08-31 2023-07-07 广西大学 一种耐亚硒酸盐的粘质沙雷氏菌及其还原特性鉴定方法
CN115505571B (zh) * 2022-11-24 2023-03-10 上海倍谙基生物科技有限公司 适用于悬浮培养lmh细胞生产禽腺病毒的无血清添加剂

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162160C (no) 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
US5118513A (en) 1987-07-02 1992-06-02 The Procter & Gamble Company Method for enhancing bioavailability of iron-calcium mineral supplements
US5840520A (en) 1989-08-28 1998-11-24 Aviron Recombinant negative strand RNA virus expression systems
US5854037A (en) 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US20060019350A1 (en) 1989-08-28 2006-01-26 Peter Palese Recombinant negative strand RNA virus expression system and vacccines
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5786199A (en) 1989-08-28 1998-07-28 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US6001634A (en) 1989-08-28 1999-12-14 Palese; Peter Recombinant negative strand RNA viruses
US6887699B1 (en) 1990-05-22 2005-05-03 Medimmune Vaccines, Inc. Recombinant negative strand RNA virus expression systems and vaccines
US6245549B1 (en) 1990-06-28 2001-06-12 Connaught Laboratories Limited Production of virus and purification of viral envelope proteins for vaccine use
GB9215834D0 (en) 1992-07-24 1992-09-09 Celltech Ltd Cell culture
US5824536A (en) 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
US7465574B2 (en) 1994-09-30 2008-12-16 Medimmune, Llc Recombinant RSV virus expression systems and vaccines
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
ATE348155T1 (de) 1996-11-20 2007-01-15 Introgen Therapeutics Inc Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
US6544785B1 (en) 1998-09-14 2003-04-08 Mount Sinai School Of Medicine Of New York University Helper-free rescue of recombinant negative strand RNA viruses
US8715940B2 (en) 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
AU7081500A (en) 1999-08-27 2001-03-26 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
PL205955B1 (pl) 2000-04-28 2010-06-30 St Jude Childrens Res Hospital Układ oparty na minimalnej liczbie plazmidów do wytwarzania infekcyjnych wirusów RNA o ujemnej nici, komórka gospodarza zawierająca taki układ, sposób wytwarzania wiriona wirusa RNA o ujemnej nici, sposób wytwarzania atenuowanego wirusa RNA o ujemnej nici, sposób wytwarzania zakaźnego wirusa o ujemnej nici do stosowania w szczepionkach i zastosowanie układu opartego na minimalnej liczbie plazmidów
ES2330411T3 (es) 2000-06-23 2009-12-10 Intervet International Bv Virus sincitial respiratorio bovino atenuado.
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
JP2005518209A (ja) 2002-02-21 2005-06-23 マウント シナイ スクール オブ メディシン 組換えマイナス鎖ウイルスｒｎａ発現系およびワクチン
WO2003086443A1 (en) 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Spray freeze dry of compositions for intranasal administration
CN1678345A (zh) 2002-04-26 2005-10-05 米迪缪尼疫苗股份有限公司 制备流感病毒的多质粒系统
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
NZ535944A (en) 2002-04-30 2007-11-30 Oncolytics Biotech Inc Viral purification method comprising a simple extraction step in which a detergent is directly added to the cell culture, thereafter, cell debris is removed from the extraction mixture by filtration or centrifugation
US6825306B2 (en) 2002-08-16 2004-11-30 The Goodyear Tire & Rubber Company Functionalized monomers for synthesis of rubbery polymers
JP2004135665A (ja) 2002-09-25 2004-05-13 Nihon Pharmaceutical Co Ltd ウイルスの分離法
US20060002862A1 (en) * 2002-12-17 2006-01-05 Medimmune Vaccines, Inc. High pressure spray-dry of bioactive materials
EP2481819A1 (en) 2003-02-25 2012-08-01 MedImmune Vaccines, Inc. Cross flow filtration in the production of stabilized influenza vaccine compositions
CA2518924C (en) * 2003-03-18 2016-06-07 Wyeth Holdings Corporation Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv
CN101410519B (zh) 2003-04-25 2013-04-24 免疫医疗有限责任公司 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法
JP2006525815A (ja) 2003-05-28 2006-11-16 ウィスコンシン・アラムナイ・リサーチ・ファウンデイション Ｐｏｌｉｉプロモーターおよびリボザイムを有する組換えインフルエンザベクター
CA2551489C (en) 2003-12-23 2013-09-03 Gregory Duke Multi plasmid system for the production of influenza virus
AU2005214090B2 (en) 2004-02-23 2008-09-11 Crucell Holland B.V. Virus purification methods
CA2566858A1 (en) 2004-05-20 2005-12-01 Id Biomedical Corporation Process for the production of an influenza vaccine
JP5147405B2 (ja) 2004-10-06 2013-02-20 メディミューン，エルエルシー 冷蔵温度安定型インフルエンザワクチン組成物
CA2592120A1 (en) * 2004-12-23 2006-07-06 Medimmune Vaccines, Inc. Non-tumorigenic mdck cell line for propagating viruses
US7790434B2 (en) 2005-06-21 2010-09-07 Medimmune, Llc Methods and compositions for expressing negative-sense viral RNA in canine cells
AU2006262381A1 (en) 2005-06-21 2007-01-04 Medimmune, Llc Methods and compositions for expressing negative-sense viral RNA in canine cells
CA2646526C (en) 2006-04-19 2016-01-12 Medimmune, Llc Methods and compositions for expressing negative-sense viral rna in canine cells
EP2007883B1 (en) * 2006-04-20 2011-12-28 Wyeth LLC Purification processes for isolating purified vesicular stomatitis virus from cell culture
JP5260525B2 (ja) 2006-09-15 2013-08-14 メディミューン，エルエルシー 高力価までウイルス増殖を支持するｍｄｃｋ細胞株と、それを用いたバイオリアクタープロセス
JP5548207B2 (ja) 2008-09-24 2014-07-16 メディミューン，エルエルシー ウイルスの精製方法
US8202726B2 (en) 2008-09-24 2012-06-19 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses

Also Published As

Publication number Publication date
KR20110074563A (ko) 2011-06-30
EP2334328A4 (en) 2012-08-29
US8785173B2 (en) 2014-07-22
US20120219588A1 (en) 2012-08-30
CN102215865B (zh) 2013-10-30
WO2010036774A1 (en) 2010-04-01
AU2009296628A1 (en) 2010-04-01
JP2012503489A (ja) 2012-02-09
AU2009296628B2 (en) 2015-01-15
CA2738024A1 (en) 2010-04-01
EP2334328A1 (en) 2011-06-22
JP5548207B2 (ja) 2014-07-16
CN102215865A (zh) 2011-10-12

Similar Documents

Publication Publication Date Title
BRPI0919250A2 (pt) métodos para a purificação de vírus
CY2020034I1 (el) Κεφαλοσπορινη που διαθετει ομαδα κατεχολης
PL3192874T3 (pl) Oczyszczanie wirusa
BRPI0920782A2 (pt) técnica para promover a fusão eficientes de instruções
BRPI0813284A2 (pt) Processos para a preparação de pirazóis
BRPI0907457A2 (pt) Absorventes
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
BRPI0907819A2 (pt) filtros
BRPI0810702A2 (pt) Catalisador
BRPI1014267A2 (pt) processo para a carbonitrificação
DE602008004490D1 (de) Werkzeugwechselsystem
NO20093389A (no) Lyddemper
BRPI0913514A2 (pt) regeneração pancreática induzida por periostina
BR112012003154A2 (pt) descanso para uma motocicleta
BRPI0914877A2 (pt) método de purificação de eritropoietina
BR112013012096A2 (pt) método para a purifação de misturas
BR112013012094A2 (pt) método para a purifação de misturas
ES1071796Y (es) Aparcamiento para bicicletas
FR2949371B3 (fr) Agrafeuse
BRPI0920524A2 (pt) método de purificação
FI20096202A0 (fi) Biologinen regeneraatti
BRPI0811533A2 (pt) Método para a produção de um vírus
DE102009037011B8 (de) Molekulares Lithographieverfahren
ES1065835Y (es) Caperuza para cetreria
FI20095795A0 (fi) Menetelmä biologiseen puhdistamiseen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.